(2R)-2-Amino-2-cyclohexyl-N-[2-(1-methyl-1H-pyrazol-4-yl)-6-oxo-5,6-dihydro-1H-[1,2]diazepino[4,5,6-cd]indol-8-yl]acetamide

(2R)-2-Amino-2-cyclohexyl-N-[2-(1-methyl-1H-pyrazol-4-yl)-6-oxo-5,6-dihydro-1H-[1,2]diazepino[4,5,6-cd]indol-8-yl]-acetamide

(2R)-2-Amino-2-cyclohexyl-N-[2-(1-methyl-1H-pyrazol-4-yl)-6-oxo-5,6-dihydro-1H-[1,2]diazepino[4,5,6-cd]indol-8-yl]acetamid

(2R)-2-Amino-2-cyclohexyl-N-[2-(1-methyl-1H-pyrazol-4-yl)-6-oxo-5,6-dihydro-1H-[1,2]diazepino[4,5,6-cd]indol-8-yl]acetamide

(2R)-2-Amino-2-cyclohexyl-N-[2-(1-méthyl-1H-pyrazol-4-yl)-6-oxo-5,6-dihydro-1H-[1,2]diazépino[4,5,6-cd]indol-8-yl]acétamide

952021-60-2

Cyclohexaneacetamide, alpha-amino-N-[5,6-dihydro-2-(1-methyl-1H-pyrazol-4-yl)-6-oxo-1H-[1,2]diazepino[4,5,6-cd]indol-8-yl]-, (alphaR)-

MFCD16038847

(2~{r})-2-Azanyl-2-Cyclohexyl-~{n}-[2-(1-Methylpyrazol-4-Yl)-9-Oxidanylidene-3,10,11-Triazatricyclo[6.4.1.0^{4,13}]trideca-1,4,6,8(13),11-Pentaen-6-Yl]ethanamide

(R)-2-amino-2-cyclohexyl-N-(2-(1-methyl-1H-pyrazol-4-yl)-6-oxo-5,6-dihydro-1H-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide

(R)-2-Amino-2-cyclohexyl-N-[2-(1-methyl-1H-pyrazol-4-yl)-6-oxo-5,6-dihydro-1H-[1,2]diazepino[4,5,6-cd]indol-8-yl]-acetamide

(R)-a-Amino-N-[5,6-dihydro-2-(1-methyl-1H-pyrazol-4-yl)-6-oxo-1H-pyrrolo[4,3,2-ef][2,3]benzodiazepin-8-yl]-cyclohexaneacetamide

952021-60-2 (free base)

9DB

CHK1_HUMAN

Cyclohexaneacetamide, a-amino-N-[5,6-dihydro-2-(1-methyl-1H-pyrazol-4-yl)-6-oxo-1H-pyrrolo[4,3,2-ef][2,3]benzodiazepin-8-yl]-, (aR)-

LIM domain kinase 1

LIM domain kinase 1/2

LIM domain kinase 2

LIMK1_HUMAN

LIMK2_HUMAN

MFCD16036287

PF-0044736;PF0044736;PF477736;PF-477736

Serine/threonine-protein kinase Chk1